×

Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate

  • US 9,273,044 B2
  • Filed: 07/09/2015
  • Issued: 03/01/2016
  • Est. Priority Date: 05/17/2010
  • Status: Active Grant
First Claim
Patent Images

1. A crystalline Form II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate, characterized by an x-ray powder diffraction pattern having peaks expressed as 2Θ

  • at;

    i) one or both of 21.16 and 21.38±

    0.20 degrees when measured against an internal silicon standard; and

    ii) at least four peaks selected from a group of peaks consisting of;

    4.48, 9.00, 13.58, 15.62, 16.48, 19.02, 19.44, 22.46, and 25.00+0.20 degrees when measured against an internal silicon standard.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×